Informatics and standards for nanomedicine technology Dennis G. Thomas, Pacific Northwest National Lab Alan Chappell, Pacific Northwest National Lab Elaine.

Slides:



Advertisements
Similar presentations
Maines Sustainability Solutions Initiative (SSI) Focuses on research of the coupled dynamics of social- ecological systems (SES) and the translation of.
Advertisements

Workshop Highlights Relevant to Nano WG High Quality Data Sets - There is a critical need for high quality data sets as input to predictive models. This.
Common Terminology Criteria for Adverse Events (CTCAE) v.4: Updating a Cancer Research Standard Ann Setser 1, Ranjana Srivastava 2, Lawrence Wright 1,
CHOICE Pathology Informatics 2010 Boston, Massachusetts DataReady ® : A Deployable Data Management and Integration System for Large-scale Cancer Repositories.
ONAMI’s - Safer Nanomaterials and Nanomanufacturing Initiative Recommendations for the FDA Nanotechnology Task Force Stacey Harper.
1 Nano WG Activities for Current Period – NPO Related Establish formal processes incorporating JIRA tracker for Nanoparticle Ontology (NPO) governance.
Overview of Biomedical Informatics Rakesh Nagarajan.
Jeffery Loo NLM Associate Fellow ’03 – ’05 chemicalinformaticsforlibraries.
Challenges in Clinical Applications for Nanotechnology N. Tony Eissa, MD Table 3.
What Do Toxicologists Do?
IANH and ISO Proposals C. Michael Garner Garner Nanotechnology Solutions Visiting Scholar Stanford University EE Department.
Cancer Nanotechnology: New Opportunities for Targeted Therapies FDA Public Meeting October 10, 2006 Piotr Grodzinski, Ph.D. Director, Nanotechnology for.
Overview Nano WG The National Cancer Institute (NCI) caBIG® Nanotechnology Working Group (Nano WG) Jessica M. Adamick 1, Nathan A. Baker 2, Alan R. Chappell.
An Integrated and Comprehensive Data Mining System for Studying Environmental Impact of Nanomaterials: NEIMiner Nano Working Group Presentation 10/13/2011.
Specimen-Related Classes in BRIDG BRIDG Overview for HL7 O&O WG Conference Call July 1, 2015 Wendy Ver Hoef NCI Contractor.
Development Principles PHIN advances the use of standard vocabularies by working with Standards Development Organizations to ensure that public health.
Informatics for Nanomanufacturing Data—Tools—Sharing Jan. 9, 2014: Report to Nano Working Group Mark Tuominen - National Nanomanufacturing Network (NNN)
Common Data Elements and Metadata: Their Roles in Integrating Public Health Surveillance and Information Systems Ron Fichtner, Chief, Prevention Informatics.
SCIENCE-DRIVEN INFORMATICS FOR PCORI PPRN Kristen Anton UNC Chapel Hill/ White River Computing Dan Crichton White River Computing February 3, 2014.
CaNanoLab Data Curation Overview NCI Nano WG June 6, 2013.
Nanomaterial Registry: Minimal Information Standards for Well-Characterized Nanomaterials in Environmental and Biological Studies Michele L. Ostraat April.
RDA Data Foundation and Terminology (DFT) IG: Introduction Prepared for RDA Plenary San Diego, March 9, 2015 Gary Berg-Cross, Raphael Ritz, Co-Chairs DFT.
NCI Review of the Clinical Trials Process 6 th Annual National Forum on Biomedical Imaging in Oncology James H. Doroshow M.D. April 7, 2005 Bethesda, Maryland.
Nano WG 12 March Why in the world do we need a nanomaterials description system? – How CODATA and VAMAS answers that question Co-Chairs John Rumble.
Grand Challenges for Nanomedicine and Nanobiology Workshop Houston, Texas August 27 th, 2007.
Department of Biomedical Informatics Service Oriented Bioscience Cluster at OSC Umit V. Catalyurek Associate Professor Dept. of Biomedical Informatics.
 BRIDG R3.0.2 was released in August 2010  The BRIDG Model passed the initial ISO Joint Initiative Council ballot as a Draft International Standard (DIS)
RDA Data Foundation and Terminology (DFT) IG: Introduction Prepared for RDA 6 th Plenary Paris, Sept. 25, 2015 Gary Berg-Cross, Raphael Ritz Co-Chairs.
DDI-RDF Discovery Vocabulary A Metadata Vocabulary for Documenting Research and Survey Data Linked Data on the Web (LDOW 2013) Thomas Bosch.
The NCIP Nanotechnology Working Group Nano WG Fall 2013 Kick-Off.
Cancer Clinical Trial Suite (CCTS): An Introduction for Users A Tool Demonstration from caBIG™ Bill Dyer (NCI/Pyramed Research) June 2008.
Cancer Nanotechnology Knowledgebase for Nanoparticle Analysis and Design caOBR-caB2B integration Nathan Baker, David Paik, and Persistent Systems.
Using the Open Metadata Registry (openMDR) to create Data Sharing Interfaces October 14 th, 2010 David Ervin & Rakesh Dhaval, Center for IT Innovations.
ISA-TAB-Nano A specification to facilitate data exchange among nanotechnology researchers and resources ISA-TAB-Nano
Chapter 6 – Data Handling and EPR. Electronic Health Record Systems: Government Initiatives and Public/Private Partnerships EHR is systematic collection.
1 Nanomedicine informatics DENNIS G. THOMAS, PACIFIC NORTHWEST NATIONAL LAB ALAN CHAPPELL, PACIFIC NORTHWEST NATIONAL LAB ELAINE FREUND, 3 RD MILLENNIUM.
Interoperability Framework Overview Health Information Technology (HIT) Standards Committee June 24, 2010 Presented by: Douglas Fridsma, MD, PhD Acting.
NCI Nano WG & ISA-TAB-Nano Overview March What is the caBIG ® Nanotechnology Working Group? NCI: National Cancer Institute –caBIG ® : Cancer Biomedical.
CaBIG ® VCDE Workspace Tactics thru June 14, 2010: How working groups fit together, and other activities Brian Davis April 1, 2010 VCDE WS Teleconference.
CaNanoLab Users Group February 2012 Use of Informatics to Expedite and Validate the Application of Nanotechnology in Biomedicine.
Open Terminology Portal (TOP) Frank Hartel, Ph.D. Associate Director, Enterprise Vocabulary Services National Cancer Institute, Center for Biomedical Informatics.
1 Nanotechnology Working Group Nathan Baker Report to Integrative Cancer Research Workspace January 11, 2012.
1 LS DAM Overview and the Specimen Core February 16, 2012 Core Team: Ian Fore, D.Phil., NCI CBIIT, Robert Freimuth, Ph.D., Mayo Clinic, Elaine Freund,
Linking Tasks, Data, and Architecture Doug Nebert AR-09-01A May 2010.
CaNanoLab Users Group Use of Informatics to Expedite and Validate the Application of Nanotechnology in Biomedicine August 2, 2012.
Health IT Workforce Curriculum Version 1.0 Fall Networking and Health Information Exchange Unit 3b National and International Standards Developing.
1 Team Based Program Design Management and Research Operations Involvement in Nanoscale Materials ES&H.
The HMO Research Network (HMORN) is a well established alliance of 18 research departments in the United States and Israel. Since 1994, the HMORN has conducted.
The Integrated National Biodefense Portfolio Initiative “One-Portfolio” Chemical Biological Defense Acquisition Initiatives Forum (CBDAIF) May 6, 2009.
Statistical Data and Metadata Exchange SDMX Metadata Common Vocabulary Status of project and issues ( ) Marco Pellegrino Eurostat
APPLICATION OF ONTOLOGIES IN CANCER NANOTECHNOLOGY RESEARCH Faculty of Engineering in Foreign Languages 1 Student: Andreea Buga Group: 1241E – FILS Coordinating.
Data types Microarray, etc. –Exchange format well established –MIAME convention, et al. Clinical chemistry, hematology, measurements –Generally a spreadsheet.
CaNanoLab Data Curation Overview NCI Nano WG June 6, 2013.
Laurie E. Locascio, Ph.D. Director, MML/NIST NIST/MML: Measurement Assurance for Biological Systems.
Semantics and the EPA System of Registries Gail Hodge IIa/ Consultant to the U.S. Environmental Protection Agency 18 April 2007.
Nano-TAB v0.5 Specification Development Effort Weekly Meeting June 8, 2010.
Uses of the NIH Collaboratory Distributed Research Network Jeffrey Brown, PhD for the DRN Team Harvard Pilgrim Health Care Institute and Harvard Medical.
A Framework for Assessing Needs Across Multiple States, Stakeholders, and Topic Areas Stephanie Wilkerson & Mary Styers REL Appalachia American Evaluation.
1 LS DAM Overview August 7, 2012 Current Core Team: Ian Fore, D.Phil., NCI CBIIT, Robert Freimuth, Ph.D., Mayo Clinic, Mervi Heiskanen, NCI-CBIIT, Joyce.
THOMSON REUTERS PROFESSIONAL SERVICES. THOMSON REUTERS PATENT CONTENT 98% of world’s filed patents.
CaNanoLab Overview January 2010 Use and Future Directions.
CaNanoLab Users Group  Building a collaborative environment enabling data sharing in the biomedical nanotechnology research community Oct. 17, 2008.
CaNanoLab Users Group April 2012 Use of Informatics to Expedite and Validate the Application of Nanotechnology in Biomedicine.
C3PR: An Introduction for Users A Tool Demonstration from caBIG™ Vijaya Chadaram Duke Cancer Center April 29, 2008.
Knowledgebase of Nanomaterial-Biological Interactions and nano-TAB caBIG ICR F2F Stacey Harper, PhD Oregon State Sharon Gaheen, SAIC May 6, 2010.
Semantic Web - caBIG Abstract: 21st century biomedical research is driven by massive amounts of data: automated technologies generate hundreds of.
Dave Iberson-Hurst CDISC VP Technical Strategy
Lixia Yao, James A. Evans, Andrey Rzhetsky  Trends in Biotechnology 
An ecosystem of contributions
Bird of Feather Session
Presentation transcript:

Informatics and standards for nanomedicine technology Dennis G. Thomas, Pacific Northwest National Lab Alan Chappell, Pacific Northwest National Lab Elaine Freund, 3 rd Millennium Sharon Gaheen, SAIC Stacey Harper, Oregon State University Juli D. Klemm, NIH/NCI David S. Paik, Stanford University Nathan A. Baker, Pacific Northwest National Lab, 1

Outline Introduction to the caBIG® Nanotechnology Working Group Overview of nanotechnology informatics challenges Research projects Ontology development PubNano resource Data exchange standards Structure-property-activity modeling 2

National Cancer Institute caBIG® Nanotechnology Working Group Government National Institutes of Health NCI, NHLBI, NIBIB, NCL Center for Disease Control Food and Drug Administration Environmental Protection Agency … Academia Washington University Pacific Northwest National Lab Oregon State Stanford MIT Georgia Tech UCLA … Industry Intel Pennsylvania NanoSystems … 3 Standards organizations ASTM E56 ISO TC229 Alliances and organizations International Alliance for NanoEHS Harmonization Oregon Nanoscience and Microtechnologies Institute National Nanotechnology Initiative National Nanomanufacturing Network NCI Nano Alliance

caBIG ® Overview ( Bench-to-bedside biomedical research infrastructure Integrates basic research to clinical research to patient care Broad deployment Extensible framework Significant use outside the cancer domain Poised for significant growth 4 Images courtesy of Juli Klemm, National Cancer Institute

Working Group Scope 5 Shaw et al., PNAS, 105: 7387.

Nano WG current areas of focus Nano-TAB development (enabling) Nanotechnology data sharing standards Working draft ready Community engaged Need to focus on applications and standards NPO support and expansion (enabling) Standard vocabulary and ontology for nanomedicine Foundation established Community engaged Need to focus on support for nano-TAB and other annotation projects Nano-QSAR (applying) Structure-activity relationships for nanomaterial-biological interactions Community engaged; participants identified Many potential areas of focus

Outline Introduction to the caBIG® Nanotechnology Working Group Overview of nanotechnology informatics challenges Research projects Ontology development PubNano resource Data exchange standards Structure-property-activity modeling 7

What is the problem? Unrealized potential due to combinatorial complexity Nanomaterials are small and diverse The promise: High density Improved biodistribution Multi-modal applications The problems: Combinatorial diversity Difficult characterization An important challenge! 8 McNeil SE. J Leukoc Biol, (3): p doi: /jlb

Size distribution data Surface morphology data Tissue biodistribution Drug loading data Anti-tumor activity In vitro drug release Zeta Potential Preparation Chemical composition of nanoparticle formulation Source: Chawla JS et al, Int J Pharm, 249, (2002), Son YJ et al, J Control Release, 91, (2003) What is the problem? Diversity of data

What is the problem? Disconnected resources and users 10

Who are the stakeholders? 11

What does the community need? The nanomedicine community has an immediate need for nanomaterial informatics: Understand nanomaterial toxicity and other biological properties Search for existing data on nanoparticle synthesis and properties Systematically represent nanomaterial structure and composition Exchange nanomaterial chemical, physical, and biological data Design nanoparticles, and other materials with custom properties for specific biological applications 12

Our solution 13 Information exchange and analysis through Data exchange standards Ontology Information resources Methodology development and applications in nanomaterial prediction: Biological activities Chemical and physical characteristics

Outline Introduction to the caBIG® Nanotechnology Working Group Overview of nanotechnology informatics challenges Research projects Ontology development PubNano resource Data exchange standards Structure-property-activity modeling 14

NanoParticle Ontology (NPO) Capture knowledge underlying nanomaterial Preparation Chemical composition Physiochemical characterization Biological function/behavior Basic Formal Ontology structure Initial focus on cancer diagnosis and therapy Current growth to include a broader range of nanotechnology concepts Supported by the caBIG ® Nano WG Available through Bioportal 15 Thomas DG, Pappu RV, Baker NA. NanoParticle Ontology for Cancer Nanotechnology Research. J Biomed Inform, in press. doi: /j.jbi /j.jbi

Example view into the NPO 16

A more detailed view of nanoparticle composition using the NPO 17

Outline Introduction to the caBIG® Nanotechnology Working Group Overview of nanotechnology informatics challenges Research projects Ontology development PubNano resource Data exchange standards Structure-property-activity modeling 18

PubNano nanomedicine resource 19 Nano-friendly interface to relevant: Ontologies (browse and search) Resources (semantic search) Materials (structural search) Literature (links back to relevant terminologies) News Driven by: NCBO Resource Index Knowledge Encapsulation Framework (KEF)

caOBR adds caBIG resources to the NCBO Resource Index caOBR: connecting caBIG with Bioportal Use the NPO and other ontologies for semantic search caOBR adds caBIG resources to NCBO Index caOBR also exposes NCBO Index to caBIG 20 NCBO BioPortal:

KEF features: Semantic MediaWiki for annotation, search, and evidence marshalling 21

KEF features: Semantic MediaWiki for annotation, search, and evidence marshalling 22

KEF features: Semantic MediaWiki for annotation, search, and evidence marshalling 23

PubNano: coming soon! Integration of: PubMed caNanoLab MICAD GEO … Coming soon to ! 24

Outline Introduction to the caBIG® Nanotechnology Working Group Overview of nanotechnology informatics challenges Research projects Ontology development PubNano resource Data exchange standards Structure-property-activity modeling 25

N ANO -TAB FOR NANOMATERIAL DATA SHARING

Target audiences and applications Audiences Biomedical researchers (Nano)-Materials scientists Toxicologists Regulatory scientists Industrial hygienists … Applications Synthesis Therapeutics, diagnostics, imaging Bionics and prosthetics Risk and exposure assessment Toxicity prediction and reduction Laboratory and occupational safety

Protocol Reference Sample Identifiers Study Factors Assay Measurements Assay Files Assay Name Data Repositories NTP (NIEHS) NCL (NCI, FDA, NIST) NBI (ONAMI) InterNano (NNN) NIL (NIOSH) STANDARDIZED Goal of nano-TAB Develop a specification to facilitate the import/export of data on nanomaterials and their characterizations to/from nanotechnology resources

What is nano-TAB? A standard tab-delimited format for describing data related to Investigations Nanomaterials Specimens Assays Leverages and extends the Investigation/Study/Assay (ISA-TAB) format Standard tab-delimited file format Developed by the European Bioinformatics Institute (EBI) for representing a variety of assays and technology types Example: MAGE-TAB Nano-TAB supports ontology-based curation Nanomaterials and concepts from the NanoParticle Ontology (NPO) as well as other ontologies

Uses and benefits Address the data sharing challenges in nanomedicine Provide a standard means for identifying nanomaterials and characterizations Enable the submission and exchange of nanomaterial data to/from nanotechnology data resources ( e.g., NBI, caNanoLab, etc.) Empower organizations to adopt standards for representing data in nanotechnology publications Provide researchers with guidelines for representing nanomaterials and characterizations to achieve cross- material comparison

nano-TAB structure 1. Describe the Investigation and Studies 2. Identify Study Samples 3. Record Assay Conditions and Measurements i_xxx.txt m_xxx.txts_xxx.txt a_xxx.txt Investigation File Study File(s)Material File(s)Assay File(s)

nano-TAB Investigation File Describes Primary investigation Associated studies, assays, and protocols Descriptive information about the study includes Design descriptors and factors Publications Assays and protocols Contacts Vertical-based spreadsheet format with columns representing multiple values

Investigation File

Investigation File (cont.)

nano-TAB structure 1. Describe the Investigation and Studies 2. Identify Study Samples 3. Record Assay Conditions and Measurements i_xxx.txt m_xxx.txts_xxx.txt a_xxx.txt Investigation File Study File(s)Material File(s)Assay File(s)

nano-TAB Study File Study files provide mappings between the samples, materials, and processing events associated with a study. Samples can be Biological materials Nanomaterials Small molecules For physical-chemical characterizations of nanomaterials, the sample is the nanomaterial. For in vitro and in vivo characterizations, the sample is the biological specimen (cell line, animal, etc.)

nano-TAB Material File Primary file for describing Nanomaterial composition and formulation Physical properties Structure Allows for Comparison of nanomaterials across nanotechnology resources Association with optional files; e.g., a Structure file for representing the 3D structure of the nanomaterial Vertical-based spreadsheet with the following sections: MATERIAL SAMPLE MATERIAL COMPONENT MATERIAL LINKAGE

Material File Material Sample Section Material Identifiers Material Characteristics Material Files

Material File Material Component Section Material Component Identifier Material Component Characteristics Material Component Files

Material File Material Linkage Section Material Linkage Identifier Material Linkage Characteristics

nano-TAB structure 1. Describe the Investigation and Studies 2. Identify Study Samples 3. Record Assay Conditions and Measurements i_xxx.txt m_xxx.txts_xxx.txt a_xxx.txt Investigation File Study File(s)Material File(s)Assay File(s)

nano-TAB Assay File Describes the protocol parameters and factors, including: Temperature Media/solvent Concentration Provides references or links to assay results, including: Measurements Instrumentation Derived data files Templates available for the “top Nano WG assays” Size by DLS (Physico-Chemical) Zeta Potential (Physico-Chemical) Hemolysis (In Vitro) Hepatocarcinoma Cytoxicity (MTT and LDH) (In Vitro) Caspase 3 Apoptosis (In Vitro) Toxicity (ADME, Single/Repeat Dose) (In Vivo) Your assay here!

nano-TAB Assay File Horizontal-based spreadsheet format with the following sections: SAMPLE NAMES PARAMETERS FACTORS ASSAY MEASUREMENTS ASSAY FILES

Assay File Size by DLS Protocol Reference Sample Identifiers Study Factors Assay Measurements Assay Files Assay Name

nano-TAB structure 1. Describe the Investigation and Studies 2. Identify Study Samples 3. Record Assay Conditions and Measurements i_xxx.txt m_xxx.txts_xxx.txt a_xxx.txt Investigation File Study File(s)Material File(s)Assay File(s)

Getting Started 1.Contact us for help! 2.Use nano-TAB template to create nano-TAB files: Leverage template glossary for definitions: 4.View example files: 5.Navigate the BioPortal ontology for terms: 6.Complete nano-TAB files and send to the nano-TAB Listserv: nano- caBIG® Nano WG nano-TAB Site:

nanoTAB Template Glossary

nano-TAB future ASTM ballot User guide Basic descriptions of elements, glossary Organized collection of examples Tutorials Easier NPO annotation and integration List of most relevant terms List of missing terms Real world applications “Client” engagement Friendly user support

nano-TAB is a community-driven effort

Additional nano-TAB reading and project team nano-TAB Project Site: ASTM nano-TAB Work Item WK28974: ISA-TAB: caBIG ICR Nano WG Data Standards Document: NanoParticle Ontology (NPO): ontology.orghttp:// ontology.org Nano-TAB project team Nathan Baker, PNNL Amy Bednar, ERDC Elaine Freund, 3 rd Millennium Marty Fritts, NCL Sharon Gaheen, SAIC Liz Hahn-Dantona, Lockheed Martin Stacey Harper, Oregon State University Mark Hoover, NIOSH Fred Klaessig, Pennsylvania Bio Nano Systems Juli Klemm, NCI CBIIT David Paik, Stanford University Sue Pan, SAIC Grace Stafford, The Jackson Laboratory Todd Stokes, Georgia Tech Dennis Thomas, PNNL

Summary Introduction to the caBIG® Nanotechnology Working Group Overview of nanotechnology informatics challenges Research projects Ontology development PubNano resource Data exchange standards Structure-property-activity modeling 51 Collaborators caBIG ® ICR Workspace, NCBO staff, ASTM, Raul Cachau, Gilbert Fragoso, Elaine Freund, Marty Fritts, Sam Gambhir, Sharon Gaheen, Liz Hahn- Dantona,Stacey Harper, Mark Hoover, Fred Klaessig, Juli Klemm, Michal Lijowski, David Paik, Sue Pan, Rohit Pappu, Persistent Systems Ltd, Daniel Rubin, Stan Shaw, Dennis Thomas, Eddie Xu, Kilian Weinberger, Trish Whetzel, …and many more! Collaborators caBIG ® ICR Workspace, NCBO staff, ASTM, Raul Cachau, Gilbert Fragoso, Elaine Freund, Marty Fritts, Sam Gambhir, Sharon Gaheen, Liz Hahn- Dantona,Stacey Harper, Mark Hoover, Fred Klaessig, Juli Klemm, Michal Lijowski, David Paik, Sue Pan, Rohit Pappu, Persistent Systems Ltd, Daniel Rubin, Stan Shaw, Dennis Thomas, Eddie Xu, Kilian Weinberger, Trish Whetzel, …and many more! Funding caBIG ® ICR Workspace and the NIH NCI caBIG® Working Group, Pacific Northwest National Laboratory HHS sector LDRD funds, as well as NIH grants U54 HG and U01 NS Funding caBIG ® ICR Workspace and the NIH NCI caBIG® Working Group, Pacific Northwest National Laboratory HHS sector LDRD funds, as well as NIH grants U54 HG and U01 NS073457